Documentos Científicos

ARTIGOS CIENTÍFICOS 

2026

         1.  de Castro MM, Dos Santos VN, Gomes MS, Ferraz ADG, Ignacio-Souza LM, Torsoni MA, Torsoni AS, Ayrizono MLS, Leal RF, Corona LP, Milanski M. Evaluation of serum and dietary profiles of vitamin B12 and folate and their association with systemic complications in patients with Crohn’s disease. Eur J Clin Nutr. 2026 May;80(5):498-505. doi: 10.1038/s41430-026-01724-3. Epub 2026 Mar 27. PMID: 41896411; PMCID: PMC13186704. https://www.nature.com/articles/s41430-026-01724-3 

2025

          1. Fonte AACFR, Cunha-Silva M, Rondon MVSS, Santos CR, Hara NH, Nagasako CK. Smoking impacts Helicobacter pylori eradication: results from a Brazilian university hospital. Arq Gastroenterol. 2025;62:e25059. doi: 10.1590/S0004-2803.24612025-059. PMID: [não disponível]. PMCID: [não disponível]. https://doi.org/10.1590/S0004-2803.24612025-059

          2. Genaro LM, Carron J, Lourenço GJ, Nagasako CK, Reis GFSR, Camargo MG, Oliveira PSP, Lima CSP, Ayrizono MLS, Azevedo AT, Leal RF. Interpretable Artificial Neural Network Models for Predicting Anti-Adalimumab Immune Complex and Serum Drug Level in Crohn’s Disease: A Proof-of-Concept Study. Pharmaceutics. 2025 Nov 29;17(12):1536. doi: 10.3390/pharmaceutics17121536. PMID: 41471051; PMCID: PMC12735940. https://www.mdpi.com/1999-4923/17/12/1536 

           3. Gudiño V, Cho JW, Caballol B, Sanzo-Machuca Á, Corraliza A, Veny M, Dotti I, Genaro LM, Melón-Ardanaz E, Masamunt MC, Esteller M, Teubel I, Robbins L, Giner À, Prieto C, Ferrer E, Leal RF, Martin-Cardona A, Loras C, Esteve M, Rimola J, Fernández-Clotet A, Ordás I, Ricart E, Panés J, Hemberg M, Salas A. TL1A-activated T cells remodel the rectal mucosa in patients with Crohn’s disease with perianal fistulising disease. Gut. 2025 Dec 25:gutjnl-2025-336246. doi: 10.1136/gutjnl-2025-336246. Epub ahead of print. PMID: 41448881. https://gut.bmj.com/content/early/2025/12/25/gutjnl-2025-336246 

          4. Pascoal LB, Rodrigues BL, Nogueira GADS, Ayrizono MLS, Oliveira PSP, Velloso LA, Leal RF. Resolvin D2 and Its Effects on the Intestinal Mucosa of Crohn’s Disease Patients: A Promising Immune Modulation Therapeutic Target. Int J Mol Sci. 2025 Jun 23;26(13):6003. doi: 10.3390/ijms26136003. PMID: 40649782; PMCID: PMC12249623. https://www.mdpi.com/1422-0067/26/13/6003 

         5. Rodrigues BL, Pascoal LB, Genaro LM, Warrak LSCA, Rodrigues BAG, Coope A, Camargo MG, Oliveira PSP, Ayrizono MLS, Velloso LA, Leal RF. In Vitro Inhibition of Endoplasmic Reticulum Stress: A Promising Therapeutic Strategy for Patients with Crohn’s Disease. Cells. 2025 Feb 13;14(4):270. doi: 10.3390/cells14040270. PMID: 39996742; PMCID: PMC11853800. https://www.mdpi.com/2073-4409/14/4/270 

2024

          1. An Y, Kim J, Kim YS, Lee J, Kim BW, Kim JI, Kim SG. Updates on the management of Helicobacter pylori infection: recommendations from the 2024 Korean Clinical Practice Guidelines. Gut Liver. 2024 Jul;18(4):419-445. doi: 10.5009/gnl240052. Epub 2024 Apr 17. PMID: 38628284; PMCID: PMC11279513. PubMed

          2. Ataide EC, Perales SR, Teramoto FD, Foratto A, Meneses CJ, Marcondes DC, Lima MTF, Nascimento LFK, Aguiar V, Cunha-Silva M, Moisés CB, Boin ISFSF. Liver transplantation after previous vena cava resection: case report. Transplant Proc. 2024 Jun;56(5):1077-1079. doi: 10.1016/j.transproceed.2024.05.001. Epub 2024 Jun 21. PMID: 38908955. https://pubmed.ncbi.nlm.nih.gov/38908955/.

          3. Ataide EC, Perales SR, Bento APN, Teramoto FD, Lima MTF, Cunha-Silva M, Moisés CB, Nascimento LFK, Aguiar V, Sevá-Pereira T, Garcia A, Boin ISFSF. Silent destruction: fulminant hepatitis and the hidden danger of weight loss drugs. Transplant Proc. 2024 Jun;56(5):1096-1097. doi: 10.1016/j.transproceed.2024.05.003. Epub 2024 Jul 5. PMID: 38969610. https://pubmed.ncbi.nlm.nih.gov/38969610/.

          4. Bittencourt PL, Nardelli MJ, Barros LL, Cançado GGL, Cançado ELR, Terrabuio DRB, Villela-Nogueira CA, Ferraz MLG, Codes L, Rotman V, Rocco R, Felga GE, Dotta DD, Martins AS, Mendes LSC, Cunha da Silva M, Hyppolito EB, Gomide GPM, Signorelli IV, Oliveira MB, Ivantes CAP, Chindamo MC, Almeida e Borges VF, Faria LC, Couto CA. Recurrence of primary sclerosing cholangitis and de novo cholangiocarcinoma after liver transplantation: results from the Brazilian Cholestasis Consortium. Clin Transplant. 2024 Oct;38(10):e70002. doi: 10.1111/ctr.70002. Epub 2024 Oct 17. PMID: 39436152. Wiley Online Library

           5. Gomes LEM, Genaro LM, de Castro MM, Ricci RL, Pascoal LB, Silva FBC, Bonfitto PHL, Camargo MG, Corona LP, Ayrizono MLS, de Azevedo AT, Leal RF. Infliximab monitoring in Crohn’s disease: a neural network approach for evaluating disease activity and immunogenicity. Ther Adv Gastroenterol. 2024 May 10;17:17562848241251949. doi: 10.1177/17562848241251949. PMID: 39664232; PMCID: PMC11632880. https://journals.sagepub.com/doi/10.1177/17562848241251949?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed 

            6. Chaim FHM, Pascoal LB, de Castro MM, Palma BB, Rodrigues BL, Fagundes JJ, Milanski M, Lopes LR, Leal RF. The resolvin D2 and omega-3 polyunsaturated fatty acid as a new possible therapeutic approach for inflammatory bowel diseases. Sci Rep. 2024 Nov 20;14(1):28698. doi: 10.1038/s41598-024-80051-8. PMID: 39562789; PMCID: PMC11576872. https://www.nature.com/articles/s41598-024-80051-8 

2023

          1. Assis-Mendoça GR, de Paula RV, Roversi FM, Bueno ML, Ferreira da Silva AC, Montes CG, Vassallo J, Cunha-Silva M. Visible intestinal peristalsis and chronic diarrhea due to a rare lymphoproliferative disease. Rev Esp Enferm Dig. 2023 Apr;115(4):200-201. doi: 10.17235/reed.2022.9042/2022. Epub 2022 Jul 27. PMID: 35899698; PMCID: PMC10134982. https://pubmed.ncbi.nlm.nih.gov/35899698/.

          2. Cunha-Silva M, França EVC, Veiga CT, Greca RD, Moraes PBS, Mazo DFC, Ataide EC, Perales SR, Monici LT, Sevá-Pereira T. 15-Year progression to liver cancer in the lack of treatment for lysosomal acid lipase deficiency: a case report. Medicine (Baltimore). 2022 Sep 2;101(35):e30315. doi: 10.1097/MD.0000000000030315. PMID: 36107601; PMCID: PMC9439781. PubMed

          3.Cunha-Silva M, França EVC, Greca RD, Mazo DFC, Costa LBE, Moraes PBS, Veiga CT, Assis-Mendonça GR, Boin IFSF, Stucchi RSB, Sevá-Pereira T. Autoimmune hepatitis and primary biliary cholangitis overlap syndrome after COVID-19. Autops Case Rep. 2023 Mar 10;13:e2023422. doi: 10.4322/acr.2023.422. PMID: 37034275; PMCID: PMC10075219. https://pubmed.ncbi.nlm.nih.gov/37034275/.

          4.Cunha-Silva M, Mazo DFC, França EVC, Greca RD, Moraes PBS, Veiga CT, Ataide EC, Perales SR, Monici LT, Sevá-Pereira T. Hemophagocytic lymphohistiocytosis in a patient with autoimmune hepatitis after SARS-CoV-2 vaccination: a case report. Medicine (Baltimore). 2023 Apr 21;102(16):e33591. doi: 10.1097/MD.0000000000033591. PMID: 37088418; PMCID: PMC10102133. https://pubmed.ncbi.nlm.nih.gov/37088418/.

          5.Cunha-Silva M, Greca RD, Sevá-Pereira T. Advanced hepatocellular carcinoma with tumor thrombosis of the inferior vena cava and pulmonary embolism. Rev Gastroenterol Mex (Engl Ed). 2023 Jul-Sep;88(3):282-283. doi: 10.1016/j.rgmxen.2023.04.010. Epub 2023 May 8. PMID: 37164799. https://pubmed.ncbi.nlm.nih.gov/37164799/.

          6.Cançado GGL, Candolo ACR, Nardelli MJ, Zitelli PM, Mazo DFC, Oliveira CP, Cunha-Silva M, Greca RD, Araújo RC, Alustau ASPT, Couto CA, Roque GRL, Farias AQ, Carrilho FJ, Pessôa MG. Cryptogenic chronic hepatitis: looking for an ideal diagnostic algorithm. Front Gastroenterol (Lausanne). 2023 Aug 1;2:1209000. doi: 10.3389/fgstr.2023.1209000. PMID: 41821805; PMCID: PMC12952394. https://pubmed.ncbi.nlm.nih.gov/41821805/.

          7. Steigleder KM, Pascoal LB, Siqueira NSN, Simino LAP, Ayrizono MLS, Ferreira MM, Fagundes JJ, Azevedo AT, Torsoni AS, Leal RF. Mathematical Models Including microRNA Levels of Mesenteric Adipose Tissue May Predict Postoperative Relapse in Crohn’s Disease Patients. Gastro Hep Adv. 2023 Sep 14;3(1):17-30. doi: 10.1016/j.gastha.2023.08.020. PMID: 39132178; PMCID: PMC11307883. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2772572323001449?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2772572323001449%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F 

2022

         1. Greca RD, Cunha-Silva M, Mazo DF, Costa LBE, Ataíde EC, Boin IFSF, Seva-Pereira T. Prevalence of hepatocellular carcinoma and its characteristics in 10 years of transplantation in a university hospital in Brazil. Transplant Proc. 2022 Jun;54(5):1304-1307. doi: 10.1016/j.transproceed.2022.03.010. PMID: 35599131. https://pubmed.ncbi.nlm.nih.gov/35599131/.

         2. Greca RD, Cunha-Silva M, Mazo DF, Costa LBE, Ataíde EC, Boin IFSF, Seva-Pereira T. Refinement of the Milan criteria: role of α-fetoprotein in liver transplantation for hepatocellular carcinoma. Transplant Proc. 2022 Jun;54(5):1310-1312. doi: 10.1016/j.transproceed.2022.04.011. https://doi.org/10.1016/j.transproceed.2022.04.011.

         3. Ataíde EC, Perales SR, Teramoto FD, Garcia A, Macedo PRA, Cunha-Silva M, Sevá-Pereira T, Foratto A, Fernandes DP, Marcondes DC, Meneses CJ, Costa LBE, Chueiri Neto F, Boin IFSF. Validation of Metroticket Score in the Preoperative Period of Liver Transplantation for Hepatocellular Carcinoma. Transplant Proc. 2022 Jun;54(5):1308-1309. doi: 10.1016/j.transproceed.2022.03.012. PMID: 35534281. https://pubmed.ncbi.nlm.nih.gov/35534281/.

         4. Cunha-Silva M, Torres LD, Fernandes MF, Lopes Secundo TM, Moreira MCG, Yamanaka A, Monici LT, Costa LBE, Mazo DF, Sevá-Pereira T. Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease. Gastroenterol Hepatol. 2022 Oct;45(8):579-584. doi: 10.1016/j.gastrohep.2021.12.004. https://doi.org/10.1016/j.gastrohep.2021.12.004.

         5. Ataíde EC, Perales SR, Teramoto FD, Garcia A, Cunha-Silva M, Sevá-Pereira T, Foratto A, Fernandes DP, Marcondes DC, Meneses CJ, Costa LBE, Chueiri Neto F, Boin IFSF. Validation of New York/California Score in the Preoperative Period of Liver Transplant for Hepatocellular Carcinoma at University of Campinas’s Hospital. Transplant Proc. 2022 Jun;54(5):1300-1303. doi: 10.1016/j.transproceed.2022.03.039. PMID: 35810016. https://pubmed.ncbi.nlm.nih.gov/35810016/.

         6. Mazo DFC, Greca RD, Cotrim HP, Chaves GV, Oliveira CPMS, Carrilho FJ, Parise ER, Sevá-Pereira T. Response to ursodeoxycholic acid may be assessed earlier to allow second-line therapy in patients with unresponsive primary biliary cholangitis. Dig Dis Sci. 2022 Jul;67(7):3079-3088. doi: 10.1007/s10620-021-07129-9. PMID: 34328667; PMCID: PMC9176117. https://pubmed.ncbi.nlm.nih.gov/34328667/.

         7. Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, Gomes NMF, Oliveira EMG, Rotman V, Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, Almeida e Borges VF, Lima Pace FH, Pessôa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Anti-mitochondrial antibody-negative primary biliary cholangitis is part of the same spectrum of classical primary biliary cholangitis. Dig Dis Sci. 2022 Jul;67(7):3305-3312. doi: 10.1007/s10620-021-07122-y. PMID: 34181166. https://pubmed.ncbi.nlm.nih.gov/34181166/.

         8. Lourenço MS, Zitelli PMY, Cunha-Silva M, Oliveira AIN, Lima RGR, Souza EO, Oliveira CP, Sevá-Pereira T, Carrilho FJ, Pessôa MG, Mazo DF. Early liver function improvement following successful treatment of chronic hepatitis C in patients with decompensated cirrhosis: a real-life study. Clinics (Sao Paulo). 2021 Nov 19;76:e3186. doi: 10.6061/clinics/2021/e3186. PMID: 34817045; PMCID: PMC8579851. https://pubmed.ncbi.nlm.nih.gov/34817045/.

         9. Tengan FM, Cunha-Silva M, Nunes D, Carrilho FJ, Mazo DFC, Pessôa MG. Evaluation of the hepatocellular carcinoma predictive scores PAGE-B and mPAGE-B among Brazilian patients with chronic hepatitis B virus infection. Ann Hepatol. 2021 Sep-Oct;24:100351. doi: 10.1016/j.aohep.2021.100351. PMID: 33940282; PMCID: PMC7833441. https://pubmed.ncbi.nlm.nih.gov/33940282/.

         10. Rodrigues BL, Dotti I, Pascoal LB, Morari J, Esteller M, Coope A, Ayrizono MLS, Salas A, Leal RF. Endoplasmic Reticulum Stress in Colonic Mucosa of Ulcerative Colitis Patients Is Mediated by PERK and IRE1 Pathway Activation. Mediators Inflamm. 2022 Feb 9;2022:6049500. doi: 10.1155/2022/6049500. PMID: 35185383; PMCID: PMC8849912. https://onlinelibrary.wiley.com/doi/10.1155/2022/6049500 

         11. Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med. 2022 Jan 20;12(1):1-15. doi: 10.5493/wjem.v12.i1.1. PMID: 35096550; PMCID: PMC8771592. https://www.wjgnet.com/2220-315X/full/v12/i1/1.htm 

2021

         1. Cunha-Silva M, Greca RD, Tengan FM, Costa LBE, Ataíde EC, Boin IFSF, Sevá-Pereira T. Cryptococcal peritonitis in patients on the liver transplant waitlist: reporting two cases with opposite outcomes. Transpl Infect Dis. 2021 Aug;23(4):e13611. doi: 10.1111/tid.13611. PMID: 33993524. https://pubmed.ncbi.nlm.nih.gov/33993524/.

         2. Greca RD, Cunha-Silva M, Costa LBE, Sevá-Pereira T, Boin IFSF. Intraductal hepatocellular carcinoma leading to obstructive jaundice. Adv Res Gastroenterol Hepatol. 2021 Feb;16(4):555941. doi: 10.19080/ARGH.2021.16.555941. https://juniperpublishers.com/argh/pdf/ARGH.MS.ID.555941.pdf.

         3. de Castro MM, Pascoal LB, Steigleder KM, Siqueira BP, Corona LP, Ayrizono MLS, Milanski M, Leal RF. Role of diet and nutrition in inflammatory bowel disease. World J Exp Med. 2021 Jan 20;11(1):1-16. doi: 10.5493/wjem.v11.i1.1. PMID: 33585174; PMCID: PMC7852575. https://www.wjgnet.com/2220-315x/full/v11/i1/1.htm 

         4. Pascoal LB, Rodrigues PB, Genaro LM, Gomes ABDSP, Toledo-Teixeira DA, Parise PL, Bispo-Dos-Santos K, Simeoni CL, Guimarães PV, Buscaratti LI, Elston JGA, Marques-Souza H, Martins-de-Souza D, Ayrizono MLS, Velloso LA, Proenca-Modena JL, Moraes-Vieira PMM, Mori MAS, Farias AS, Vinolo MAR, Leal RF. Microbiota- derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples. Gut Microbes. 2021 Jan-Dec;13(1):1-9. doi: 10.1080/19490976.2021.1874740. PMID: 33550892; PMCID: PMC7889267.  https://www.tandfonline.com/doi/10.1080/19490976.2021.1874740?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed 

2020

          1. Greca RD, Cunha-Silva M, Costa LBE, Tengan FM, Sevá-Pereira T, Boin IFSF. Massive iron overload and acute-on-chronic liver failure in a patient with Diamond–Blackfan anaemia: a case report. Ann Hepatol. 2021 Jan-Feb;20:100253. doi: 10.1016/j.aohep.2020.08.074. PMID: 33007583. https://pubmed.ncbi.nlm.nih.gov/33007583/.

          2.  Chaim FDM, Pascoal LB, Chaim FHM, Palma BB, Damázio TA, da Costa LBE, Carvalho R, Cazzo E, Gestic MA, Utrini MP, Milanski M, Chaim EA, Leal RF. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study. Sci Rep. 2020 May 22;10(1):8496. doi: 10.1038/s41598-020-65556-2. PMID: 32444690; PMCID: PMC7244764. https://www.nature.com/articles/s41598-020-65556-2 

          3. da Silva FAR, Pascoal LB, Dotti I, Setsuko Ayrizono ML, Aguilar D, Rodrigues BL, Arroyes M, Ferrer-Picon E, Milanski M, Velloso LA, Fagundes JJ, Salas A, Leal RF. Whole transcriptional analysis identifies markers of B, T and plasma cell signaling pathways in the mesenteric adipose tissue associated with Crohn’s disease. J Transl Med. 2020 Jan 30;18(1):44. doi: 10.1186/s12967-020-02220-3. PMID: 32000799; PMCID: PMC6993458. https://link.springer.com/article/10.1186/s12967-020-02220-3 

2019

          1. Cunha-Silva M, Costa JG, Faria GAS, Massuda JY, Cintra ML, Costa LBE, Assad VM, Ataíde EC, Mazo DFC, Sevá-Pereira T. Diarrhea: a missed D in the 4D glucagonoma syndrome. Autops Case Rep. 2019 Oct-Dec;9(4):e2019129. doi: 10.4322/acr.2019.129. PMID: 31807436; PMCID: PMC6880768. https://pubmed.ncbi.nlm.nih.gov/31807436/.

          2. Imbrizi MR, Magro DO, Lopes Secundo TM, Cunha-Silva M, Kotze PG, Montes CG, Almeida JRS, Cabral VLR. Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients. Intest Res. 2019 Jan;17(1):63-69. doi: 10.5217/ir.2018.00077. PMID: 30678446; PMCID: PMC6361029. https://pubmed.ncbi.nlm.nih.gov/30678446/.

          3. Cunha-Silva M, Mazo DFC, Corrêa BR, Lopes TM, Arrelaro RC, Ferreira GL, Rabello MI, Sevá-Pereira T, Escanhoela CAF, Almeida JRS. Lysosomal acid lipase deficiency leading to liver cirrhosis: a case report of a rare variant mutation. Ann Hepatol. 2019 Jan-Feb;18(1):230-235. doi: 10.5604/01.3001.0012.7930. https://www.sciencedirect.com/science/article/pii/S166526811930328X.

          4. Mazo DFC, Chagas AL, Cunha-Silva M, Mattos AZ, de Mattos AA, Ribeiro TC, Pugliese V, Carrilho FJ, Sevá-Pereira T. Evolution of diagnostic criteria for acute kidney injury in patients with decompensated cirrhosis: a prospective study in a tertiary university hospital. Clin Exp Hepatol. 2019;5(4):310-315. doi: 10.5114/ceh.2019.89614. PMID: 31998771; PMCID: PMC6971375. https://pubmed.ncbi.nlm.nih.gov/31998771/.

2018

          1. Mazo DFC, Chagas AL, Cunha-Silva M, Mattos AZ, Mattos AA, Ribeiro TC, Pugliese V, Carrilho FJ, Sevá-Pereira T. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection. Eur J Gastroenterol Hepatol. 2019 Jan;31(1):80-85. doi: 10.1097/MEG.0000000000001269. PMID: 30234691. https://pubmed.ncbi.nlm.nih.gov/30234691/.

          2. Cunha-Silva M, Costa JG, Costa LBE, Mazo DFC, Sevá-Pereira T. Multiple hepatic metastases of cardiac angiosarcoma. Autops Case Rep. 2018 Oct-Dec;8(4):e2018058. doi: 10.4322/acr.2018.058. PMID: 30584518; PMCID: PMC6301855. https://pubmed.ncbi.nlm.nih.gov/30584518/.

          3. Cunha-Silva M, Mazo DFC, Ortega CD, Costallat LTL, Sevá-Pereira T. Hand-foot syndrome due to hepatitis C therapy. Autops Case Rep. 2018 Jul-Sep;8(3):e2018036. doi: 10.4322/acr.2018.036. PMID: 30148172; PMCID: PMC6100463. https://pubmed.ncbi.nlm.nih.gov/30148172/.

2017

         1. Cunha-Silva M, Sipahi AM, Visconti TAC, D’Albuquerque LAC, Mazo DFC, Sevá-Pereira T. Localized gastrointestinal amyloidosis presenting with protein-losing enteropathy and massive hemorrhage. Autops Case Rep. 2018 Apr-Jun;8(2):e2018021. doi: 10.4322/acr.2018.021. PMID: 29922674; PMCID: PMC6000882. https://pubmed.ncbi.nlm.nih.gov/29922674/.

         2. Mazo DFC, Chagas AL, Mattos AZ, Mattos AA, Ribeiro TC, Pugliese V, Cunha-Silva M, Carrilho FJ, Sevá-Pereira T. Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors. Braz J Infect Dis. 2018 Nov-Dec;22(6):441-447. doi: 10.1016/j.bjid.2018.10.001. PMID: 30447441; PMCID: PMC9428148. https://pubmed.ncbi.nlm.nih.gov/30447441/.

         3. Coope A, Pascoal LB, da Silva FAR, Botezelli JD, Ayrizono MLS, Milanski M, Camargo MG, Planell N, Portovedo M, Dias CB, Fagundes JJ, Leal RF. Transcriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn’s Disease Patients. Int J Inflam. 2017;2017:7646859. doi: 10.1155/2017/7646859. Epub 2017 Apr 9. PMID: 28487813; PMCID: PMC5401739. https://onlinelibrary.wiley.com/doi/10.1155/2017/7646859